modern

Using artificial intelligence to crack the genome of the corona virus. Illustration: depositphotos.com

Artificial intelligence offers drugs against the corona virus from the protein sequence only

IBM's artificial intelligence model was able to find compounds that bind to different sites on target proteins against the corona disease caused by the covid virus and this without knowing the binding mechanism of the virus
mRNA. Illustration: depositphotos.com

Moderna and IBM will investigate the development of mRNA-based therapies with the help of quantum computing and artificial intelligence

As part of the collaboration, IBM will provide modern scientists with access to quantum computing systems, and they will learn how quantum computing technologies can be applied to problems that were previously intractable for classical computers.
Corona virus. Image: depositphotos.com

Moderna is seeking approval for an updated South African variant vaccine

Corona vaccine. Photo: depositphotos.com

Moderna: "The vaccine is effective against the British variant and less so against DRAP, but still sufficient

This is what the company announced today after laboratory studies that included serum samples of vaccinators * Moderna will make changes to the vaccine so that it will also protect those infected with the new variants
Corona vaccine. Illustration: depositphotos.com

Moderna reports receiving FDA approval for the company's COVID-19 vaccine

Moderna reported on Friday the receipt of FDA approval for the company's COVID-19 vaccine in the US, which will also be followed by approval for the vaccine in Israel as happened with Pfizer's vaccine last week
The process of developing the corona vaccine. Public relations photography, Moderna

Moderna applies to the FDA for emergency approval for the vaccine

Moderna announces the analysis of preliminary efficacy findings in the results of the phase 3 trial of its COVE vaccine for the treatment of COVID-19 as well as the submission of the trial findings for emergency approval by the FDA
mRNA vaccine for corona. Illustration: depositphotos.com

Moderna's COVID-19 vaccine achieved 94.5% efficacy in the clinical trial

A first interim analysis of the trial's findings included 95 participants who were infected with Corona, 90 of whom are from the control group * All five who got sick despite the vaccine were asymptomatic or in a mild condition * Israel between